INTRODUCTION {#S1}
============

Piwi-interacting RNAs (piRNAs) have diverse roles in gene regulation and development but are best known for silencing transposons ([@R45]). Loss of piRNAs often leads to sterility ([@R61]). In *Caenorhabditis elegans*, however, disabling the piRNA pathway does not lead to immediate sterility but instead to a gradual loss of fertility over numerous generations ([@R26]; [@R59]). *C. elegans* piRNAs initiate mRNA entry into an endogenous RNAi pathway in which small RNAs called WAGO-class 22G-RNAs are produced antisense to the mRNA target ([@R8]; [@R9]; [@R35]; [@R40]). WAGO-class 22G-RNAs are often classified as small interfering RNAs (siRNAs), although, unlike canonical siRNAs, they are not derived from double-stranded RNA (dsRNA) and are not processed by Dicer ([@R2]; [@R6]; [@R25]; [@R46]; [@R58]). Instead, they are produced by an RNA-dependent RNA polymerase in association with a collection of proteins called the Mutator complex ([@R6]; [@R48]). A subset of 22G-RNAs bind HRDE-1, a nuclear Argonaute that promotes transgenerational inheritance of RNAi and is required for transgenerational fertility ([@R15]). The 22G-RNAs produced downstream of piRNAs, particularly those bound by HRDE-1, are thought to provide a memory of piRNA activity that seemingly persists over multiple generations, which may explain why the loss of the primary Piwi Argonaute *prg-1* does not cause immediate sterility ([@R8]; [@R15]; [@R40]; [@R57]).

piRNAs are methylated at their 3′ ends by the 3′-2′-O-methyltransferase HEN1 ([@R45]). First characterized in *Arabidopsis*, methylation protects small RNAs from 3′--5′ trimming and decay ([@R11]; [@R27]; [@R31]; [@R33]; [@R37]; [@R43]; [@R51]; [@R74]). Small RNAs are bound at both their 5′ and 3′ ends by the Piwi/Argonaute they associate with. The 3′ end is anchored in the PAZ domain, which likely protects the small RNA from nucleases and other base-modifying enzymes. Small RNAs with extensive target complementarity at their 3′ ends are released from the PAZ domain to facilitate base pairing with their targets ([@R32]). In animals, piRNAs and siRNAs typically have extensive complementarity to their targets and are methylated, whereas miRNAs interact with only partial complementarity and are not methylated ([@R45]). In *Drosophila*, methylation protects extensively base-paired small RNAs from target-directed trimming and tailing, thus explaining the link between target complementarity and methylation ([@R4]). However, this simple complementarity rule for whether or not a class of small RNAs is methylated cannot be strictly applied to *C. elegans*, as most siRNAs, which share perfect complementarity to their targets, are not methylated ([@R11]; [@R31]; [@R43]). The only class of small RNAs, aside from piRNAs, that is thought to be methylated in *C. elegans* is one of two branches of the 26G-RNA pathway involving the Argonaute ERGO-1 ([@R11]; [@R31]; [@R43]; [@R50]; [@R63]).

*C. elegans* bearing mutations in the *HEN1* ortholog *henn-1* display only modest loss of fertility under normal growth conditions ([@R11]; [@R31]; [@R43]). Here, however, we discover a critical role for *henn-1* in preserving fertility and germline integrity from one generation to the next as we explore its role in piRNA, miRNA, and RNAi pathways in the worm.

RESULTS {#S2}
=======

*henn-1* Is Required for Transgenerational Fertility {#S3}
----------------------------------------------------

In *C. elegans*, the Piwi ortholog *prg-1* promotes germline immortality. In the absence of *prg-1*, sterility ensues over \~35--80 generations ([@R59]). Given the presumed role of HENN-1 in methylating the 3′ ends of piRNAs to promote their stability, we used two separate approaches to test if, like *prg-1*, *henn-1* is required for germline immortality. In the first set of experiments, modeled after [@R15], we measured the number of progeny produced from recently outcrossed (3×) *henn-1(pk2295)* mutants across \~28 generations at 25°C. In parallel, we measured the brood sizes of wild-type animals and freshly outcrossed (1×) *prg-1(n4357)* mutants as controls. At \~5 generations, the first generation at which measurements were taken, both *henn-1* and *prg-1* mutants displayed modest reductions in the numbers of progeny they produced relative to wild-type animals (p values = 0.00004 and 0.00002, respectively) ([Figures 1A](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}). By \~28 generations, the mean numbers of progeny produced by *henn-1* and *prg-1* mutants had diminished to 8 and 23, respectively, compared to 201 in wild-type (p = 0.00007 and p = 0.0002, respectively, for comparisons to wild-type), and many of the mutant animals were sterile ([Figures 1A](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}).

The NL4415\[*henn-1(pk2295)*\] strain used in these experiments has been propagated over numerous generations and may have acquired background mutations that could contribute to defects in fertility. Thus, we repeated the brood size experiments with a fresh *henn-1* deletion allele generated using CRISPR-Cas9. The new *henn-1(ram13)* allele displayed fertility rates indistinguishable from wild-type animals at \~5 generations when grown at 25°C (p = 1.0). After \~20 generations, however, animals containing the fresh *henn-1* deletion produced only 33 progeny/animal on average and exhibited a high incidence of sterility, whereas wild-type animals produced 169 progeny on average and were all fertile (p = 0.0009 for comparison to wild-type) ([Figures 1B](#F1){ref-type="fig"} and [S1B](#SD1){ref-type="supplementary-material"}).

We then used a second assay for transgenerational fertility, modeled after [@R59], in which we followed the fertility of 10 independent *henn-1(pk2295)* and *prg-1(n4357)* mutant lines, scoring at every generation whether or not each line was fertile. All of the *henn-1* mutant lines had become sterile by 29 generations at 25°C ([Figure S1C](#SD1){ref-type="supplementary-material"}). However, sterility occurred after only 12 generations in *prg-1* mutants ([Figure S1C](#SD1){ref-type="supplementary-material"}). Additionally, *prg-1* mutants displayed progressive sterility at 20°C across 30 generations, whereas *henn-1* mutants did not ([Figure S1D](#SD1){ref-type="supplementary-material"}).

To determine if the 3′-2′-O-methyltransferase activity of *henn-1* is required for transgenerational fertility, we tested whether animals containing a mutation that disrupts the catalytic site of *henn-1* also display a progressive decline in fertility. Indeed, between 1 and 10 generations at 25°C, *henn-1(pk2452)* mutants displayed an \~55% reduction in the mean number of progeny they produced (p = 0.0072) ([Figure S1E](#SD1){ref-type="supplementary-material"}). Finally, to determine if defects in piRNA function are likely responsible for the transgenerational sterility of *henn-1* mutants, we assessed whether the loss of the other class of small RNAs presumed to be methylated in *C. elegans*, ERGO-1-class 26G-RNAs, affects fertility. Mutations in *ergo-1* did not cause transgenerational sterility ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}). Therefore, our results suggest that *henn-1*, and hence presumably methylation, is important for the role of piRNAs in maintaining germline immortality, although it is possible that *henn-1* has additional unknown roles that contribute to its phenotype.

Sterility Ensues after Reestablishing WAGO-Class 22G-RNA Production in the Absence of *henn-1* {#S4}
----------------------------------------------------------------------------------------------

Disabling both the piRNA pathway and the WAGO-class 22G-RNA pathway and then restoring just the WAGO pathway causes sterility, despite neither pathway being essential for fertility under normal conditions ([@R19]; [@R49]). In the animals in which the WAGO pathway is restored in the absence of piRNAs, essential genes are misrouted into the RNAi pathway for silencing ([@R19]; [@R49]). It is not clear if this role for piRNAs in preventing silencing of essential genes is related to its role in maintaining germline immortality. However, given that *henn-1* is required for piRNA stability, we tested if it is also required for fertility upon reestablishing the WAGO pathway. To reestablish the WAGO pathway, we crossed two strains containing distinct mutations, *mut-16* or *mut-14 smut-1*, that cause loss of WAGO-class 22G-RNAs, such that their progeny received functional copies of *mut-14* and *smut-1* from one parent and a functional copy of *mut-16* from the other parent. Thus, although neither parent was capable of WAGO-class 22G-RNA formation, the pathway was restored in their progeny ([Figure 1C](#F1){ref-type="fig"}). If *henn-1* is required for the role of piRNAs in establishing proper RNA silencing, we would predict that introducing a *henn-1* mutation into the two strains used to reestablish the WAGO pathway would lead to sterility in the offspring of the cross, as we previously showed occurs when the two strains contain mutations in *prg-1* ([@R49]). Indeed, the vast majority of *henn-1* mutants in which WAGO-class 22G-RNA production was restored were sterile, whereas, in the presence of *henn-1*, most animals were fertile (p = 0.02 for the differences between *henn-1*^+/+^ and *henn-1*^−/−^) ([Figure 1D](#F1){ref-type="fig"}).

Reactivating WAGO-class 22G-RNA production causes sterility specifically in the absence of maternally contributed *prg-1* ([@R19]; [@R49]). To determine if, similarly, a maternal contribution of *henn-1* is specifically required for fertility when reestablishing WAGO-class 22G-RNA production, we set up crosses to reactivate the WAGO pathway in which only one parent was mutant for *henn-1*. The progeny of animals that received a paternal, but not a maternal, contribution of wild-type *henn-1* were mostly sterile ([Figure 1D](#F1){ref-type="fig"}). In contrast, progeny that received a maternal contribution of wild-type *henn-1*, regardless of whether they received a paternal contribution of wild-type *henn-1*, were mostly fertile, indicating that, like *prg-1*, a maternal contribution of *henn-1* is required for fertility when reestablishing WAGO-class 22G-RNA production ([Figure 1D](#F1){ref-type="fig"}). It is unlikely that background mutations are responsible for the sterility that ensues after restoring the WAGO pathway, as both old and new alleles of *henn-1* displayed similar proportions of sterile animals (\~83%--90%) ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}).

We next assessed whether *henn-1* mutants display germline atrophy or defects in germ cell proliferation similar to those exhibited by *prg-1/piwi* mutants as they go sterile either over multiple generations or upon reestablishing WAGO-class 22G-RNA production ([@R19]; [@R26]; [@R49]). To do so, we introduced a germ cell marker, *glh-1::GFP* ([@R5]), into *henn-1(pk2295)* mutants and examined adult animals after several generations at 25°C. At ten generations, many of the *glh-1::GFP; henn-1(pk2295)* mutants were sterile and displayed diminutive and underproliferated germlines reminiscent of sterile *prg-1* mutants ([Figures 1F](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}) ([@R19]; [@R26]; [@R49]). Thus, *henn-1* is required for proper maintenance of the germline over multiple generations. That *henn-1* and *prg-1* have a similar impact on germline integrity is further evidence that *henn-1* is important for the role of piRNAs in preserving generational fertility.

*henn-1* Impacts WAGO-Class 22G-RNA Formation throughout Development {#S5}
--------------------------------------------------------------------

*henn-1* is required for piRNA accumulation in embryos and L1 larvae but mostly dispensable later in development ([@R11]). This suggests that methylation may not be required for piRNA stability in the proliferating germline. To assess the impact of *henn-1* on piRNA stability in the germline, we sequenced small RNAs from dissected distal gonads of adult animals, which are comprised primarily of germ cells ([@R47]), from wild-type and *henn-1* mutants. We also sequenced small RNAs from mixed-stage embryos, which have a variable number of somatic cells but contain only two germline precursor cells. To determine if piRNAs are more susceptible to decay in the germline precursor cells of embryos compared to the proliferated germlines of adults, an indicator of which is trimming or truncation at the 3′ ends, we calculated the proportions of piRNA reads that displayed 1- to 5-nt truncations in our high-throughput sequencing libraries. In *henn-1* mutant embryos, we observed an \~2.9-fold increase in the proportion of piRNAs that were truncated relative to wild type (p = 0.00005), whereas in gonads, we observed a more modest 1.5-fold increase (p = 0.002) ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). piRNA trimming in gonads was almost exclusively limited to 1 nt, whereas in embryos we observed 1- to 2-nt truncations ([Figure 2A](#F2){ref-type="fig"}). To determine if the elevated levels of piRNA truncations in *henn-1* mutants corresponded to a reduction in mature piRNA levels, we used TaqMan qRT-PCR, to measure the levels of three piRNAs. Unlike high-throughput sequencing library preparation, TaqMan small RNA qRT-PCR is not thought to be hindered by 3′ methylation. Each of the piRNAs tested was strongly depleted in *henn-1* mutant embryos, indicating that the relatively high levels of truncations we observed in embryos were coincident with their decay (p ≤ 0.01) ([Figure 2C](#F2){ref-type="fig"}). In contrast, we did not detect any differences in piRNA levels in *henn-1* mutant gonads, despite the modest increase we observed in piRNA trimming (p = 0.5--1.0) ([Figure 2D](#F2){ref-type="fig"}). To confirm our qRT-PCR results, we examined 21UR-1 by northern blot. Consistent with our qRT-PCR results, 21UR-1 levels were strongly depleted in *henn-1*-mutant embryos but appeared unchanged in *henn-1*-mutant adults relative to wild-type animals ([Figure 2E](#F2){ref-type="fig"}). Our results suggest that *henn-1*, and thus presumably methylation, is important for protecting piRNAs from decay in early embryos but is largely dispensable in the proliferated germline of adult animals.

piRNAs trigger secondary siRNA (WAGO-class 22G-RNA) production from their targets, and consequently, 22G-RNA production from many WAGO target genes is reduced in *prg-1* mutants ([@R35]). To identify the requirement for *henn-1* in triggering WAGO-class 22G-RNA production, we subjected small RNAs from wild-type and *henn-1(pk2295)* mutant embryos, L4 larvae, and gravid adults to high-throughput sequencing. In each of the developmental stages, we observed a similar modest loss of 22G-RNAs from WAGO targets in *henn-1* mutants ([Figure 2F](#F2){ref-type="fig"}). Consistent with previous studies, WAGO-class 22G-RNAs did not display 3′ truncations in the absence of *henn-1*, indicating that they are indirectly affected by loss of *henn-1* activity ([Figure 2A](#F2){ref-type="fig"}) ([@R11]; [@R31]; [@R43]). A total of \~75% of WAGO targets depleted of 22G-RNAs in *henn-1* mutant adults were also depleted of 22G-RNAs in *prg-1* mutants, indicating that henn-1 primarily affects piRNA-dependent 22G-RNAs ([Figure S2](#SD1){ref-type="supplementary-material"}) ([@R49]). The majority of WAGO target genes depleted of 22G-RNAs \>50% in embryos were also depleted of 22G-RNAs \>50% in adults and L4 stage larvae ([Figure 2G](#F2){ref-type="fig"}). These results suggest that *henn-1* impacts piRNA-dependent 22G-RNA production throughout development despite the requirement for *henn-1* in piRNA stability being restricted to early stages of development.

Loss of *henn-1* Has Little Impact on Gene Expression in the Germline {#S6}
---------------------------------------------------------------------

Because the loss of *henn-1* has a modest impact on the health of animals grown at 20°C ([@R11]; [@R31]; [@R43]), we could examine its role in regulating gene expression in the germline, where piRNAs are active, without developmental defects confounding the results. However, a caveat to this approach is that *henn-1* is not required for piRNA stability in adults, the stage at which we are able to dissect germline tissue. Nonetheless, because many piRNA-dependent 22G-RNAs are depleted in *henn-1* mutant adults at 20°C, we could the assess the impact of their loss on germline gene expression. Therefore, we did mRNA sequencing using the same wild-type and *henn-1(pk2295)* RNA samples from adult gonads that were used for the small RNA high-throughput sequencing analysis described above ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). We then performed differential gene expression analysis applying an arbitrary 1.3-fold change cutoff, which excludes many genes that are differentially expressed based on a false discovery rate of 0.05 but which increases the likelihood that differences observed are biologically relevant. As we predicted based on the health of the animals at 20°C, only modest changes in mRNA expression were observed in *henn-1* mutants relative to wild-type animals, with 238 genes significantly upregulated and 50 genes significantly downregulated \>1.3-fold ([Figure 3A](#F3){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}).

In parallel, we performed differential expression analysis of small RNAs from these samples, which we had earlier used in our trimming analysis, to assess more comprehensively the impact of *henn-1* on 22G-RNA levels. We identified 1,084 WAGO target genes that were depleted of 22G-RNAs \>1.3-fold ([Figure 3B](#F3){ref-type="fig"}; [Table S2](#SD3){ref-type="supplementary-material"}). A small subset of genes targeted by CSR-1, an Argonaute implicated in licensing genes for expression ([@R17]; [@R54]; [@R67]), also displayed altered levels of 22G-RNAs ([Figure 3B](#F3){ref-type="fig"}; [Table S2](#SD3){ref-type="supplementary-material"}). piRNA levels in our sequencing data appeared elevated in *henn-1* mutants, likely due to increased capture efficiency, as 3′-2′-O-methylation inhibits RNA ligation and reverse transcription during library preparation, despite our efforts to minimize such biases ([Table S2](#SD3){ref-type="supplementary-material"}) ([@R44]).

Among the upregulated genes, 20% are histones, representing each of the core families---H2A, H2B, H3, and H4 ([Figures 3C](#F3){ref-type="fig"} and [S3A](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}). As these are multicopy gene families and the effects are modest (1.35- to 1.86-fold), it is unclear what impact this might have on the chromatin landscape. A small subset of histone genes had reduced levels of 22G-RNAs in *henn-1* mutants, suggesting that *henn-1*-dependent 22G-RNAs may have a role in regulating histones, although it is possible that altered cell physiology in *henn-1* mutants indirectly impacts histone levels ([Figure S3A](#SD1){ref-type="supplementary-material"}; [Table S2](#SD3){ref-type="supplementary-material"}). The levels of several genes involved in RNAi---*sid-1, rde-11*, and *wago-4*---were modestly reduced in *henn-1* mutants, each of which also had reduced levels in *henn-1* in a microarray-based study using whole animals ([Figures 3C](#F3){ref-type="fig"} and [S3B](#SD1){ref-type="supplementary-material"}--[S3D](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}) ([@R31]). *sid-1* and *rde-11* are required for optimal exogenous RNAi, and their downregulation could explain the reduced RNAi efficiency previously observed in *henn-1* mutants ([@R11]; [@R31]; [@R68]; [@R71]; [@R76]). WAGO-4 transports siRNAs from parent to progeny to promote multigenerational RNAi, and thus, its misregulation may have a role in the transgenerational sterility of *henn-1* mutants ([@R64]; [@R70]). However, *wago-4* levels were reduced by only \~1.3-fold in *henn-1* mutants, suggesting that other factors likely contribute to the transgenerational sterility of *henn-1* mutants.

As piRNAs are well known for their role in regulating transposons, we used a more targeted approach to assess the role of *henn-1* in transposon regulation. We aligned our RNA sequencing (RNA-seq) reads from wild-type and *henn-1* mutants to each of 152 transposon family consensus sequences and compared the levels of small RNAs and mRNAs produced from each family ([@R29]). Only five transposon families were misregulated in *henn-1* mutants, most notably MIRAGE, which was upregulated \~4-fold and is also upregulated in *prg-1* mutants ([Figure 3D](#F3){ref-type="fig"}; [Table S3](#SD4){ref-type="supplementary-material"}) ([@R41]). Desilencing of MIRAGE is partially responsible for the sterility of several heterochromatin factor mutants linked to small-RNA-mediated gene silencing ([@R41]). Most 22G-RNAs produced from MIRAGE were upregulated in *henn-1*, contrary to what would be expected if these siRNAs were involved in RNA silencing ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}; [Table S3](#SD4){ref-type="supplementary-material"}). It is possible that MIRAGE is indirectly affected by *henn-1*, although given that it is also upregulated in *prg-1* mutants, it may be that other elements of the pathway obscure the relationship between 22G-RNA production and RNA silencing. We, therefore, examined the relationship between *henn-1*-dependent 22G-RNAs and mRNA misregulation in *henn-1* mutants more generally. Genes depleted of 22G-RNAs in *henn-1* mutants had a tendency to be upregulated, although there was considerable variation and some were instead downregulated ([Figure 3G](#F3){ref-type="fig"}). This inconsistency could be due to complex feedback between mRNA expression and 22G-RNA production. The numbers of predicted piRNA target sites in mRNAs misregulated in *henn-1* mutants, as determined by sequence complementarity and by PRG-1-mRNA co-immunoprecipitation (coIP) (CLASH), were similar between genes that were upregulated and those that were downregulated ([Table S1](#SD2){ref-type="supplementary-material"}) ([@R56]; [@R69]; [@R77]). However, all but one misregulated gene had multiple predicted piRNA target sites in at least one of the two target prediction methods, and it is not clear which genes are bona fide piRNA targets ([Table S1](#SD2){ref-type="supplementary-material"}). Further studies exploring the relationship between piRNA-mRNA interactions and gene expression may shed light on these results.

HRDE-1 is a nuclear Argonaute that associates with a subset of WAGO-class 22G-RNAs and is required for RNAi inheritance, piRNA-mediated transgenerational gene silencing, and at 25°C for transgenerational fertility ([@R8]; [@R15]; [@R40]; [@R57]). Because *henn-1* is also required for transgenerational fertility at 25°C and for piRNA stability and may, therefore, promote the production of HRDE-1-associated 22G-RNAs, we examined the overlap between 22G-RNAs that are *henn-1*-dependent and those that associate with HRDE-1 or with WAGO-1, a WAGO Argonaute not implicated in transgenerational inheritance. Of the \~1,100 genes depleted of 22G-RNAs in *henn-1* mutants, \~66% were enriched for 22G-RNAs that co-immunoprecipitated (coIP'd) with a FLAG::HRDE-1 fusion protein ([Figure 3H](#F3){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}). Only \~40% were enriched for 22G-RNAs that coIP'd with GFP::FLAG::WAGO-1, the majority of which also coIP'd with HRDE-1 ([Figure 3H](#F3){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}).

Together, our results indicate that *henn-1* is important for the production of piRNA-dependent and HRDE-1-associated 22G-RNAs. However, the consequence of the loss of *henn-1* on gene expression in the adult germline is modest under the optimal growing conditions in which our experiments were done. Given that growth at elevated temperatures over multiple generations exacerbates the *henn-1* phenotype, more dramatic defects in gene expression almost certainly underlie the progressive sterility of *henn-1* mutants. Unfortunately, the severe germline defects that occur under such conditions would complicate germline dissections and confound RNA-seq analysis of gene expression.

Exogenous siRNAs Are Modified at Their 3′ Ends {#S7}
----------------------------------------------

Both classes of small RNAs that are presumably methylated in *C. elegans*, piRNAs, and ERGO-1-class 26G-RNAs are thought to function primarily to trigger WAGO-class 22G-RNA production ([Figure 4A](#F4){ref-type="fig"}) ([@R12]). Thus, we hypothesized that methylation is specific to small RNAs that act upstream of the WAGO pathway. Exogenous siRNAs produced from dsRNA administered during RNAi treatment bind to the Argonaute RDE-1 and like piRNAs and ERGO-1-class 26G-RNAs act as primary small RNAs to trigger 22G-RNA production ([@R46]; [@R58]; [@R60]). If methylation is specific to primary small RNAs upstream of WAGO-class 22G-RNAs, exogenous siRNAs should also be methylated. To address this, we did RNAi against the endogenous gene *pos-1* in wild-type animals and tested whether primary and secondary siRNAs (i.e., WAGO-class 22G-RNAs) corresponding to *pos-1* were modified at their 3′ ends by using a high-throughput sequencing approach. To enrich for small RNAs containing 3′ modifications, a fraction of the small RNA sample from animals undergoing *pos-1* RNAi was treated with sodium periodate, an oxidizing agent that disrupts the 3′ base of unmethylated, but not 2′-O-methylated, small RNAs, thereby inhibiting adaptor ligation to the 3′ end ([@R53]). Although sodium periodate treatment does not directly assess methylation, it is a widely used proxy that is not known to be confounded by other small RNA chemical modifications ([@R73]). The other fraction was treated similarly but was not oxidized. Each of the two fractions was further split between an RNA 5′ polyphosphatase treatment, which reduces the triphosphate group found on 22G-RNAs to monophosphate, thereby enabling capture by 5′ ligation during small RNA library preparation ([@R46]; [@R58]), and a control treatment. The fractions treated with RNA 5′ polyphosphatase would presumably yield mostly 22G-RNAs, as this class of small RNAs is far more abundant than primary siRNAs ([@R46]; [@R58]). The fractions that were not treated with RNA 5′ polyphosphatase would likely exclude 22G-RNAs because of an adaptor-ligation-incompatible 5′ triphosphate group. The four small RNA fractions were subjected to library preparation and high-throughput sequencing.

Small RNAs derived from *pos-1* in both oxidized and non-oxidized libraries in which the small RNAs were not treated with RNA 5′ polyphosphatase displayed features associated with primary siRNAs: similar proportions of 22- and 23-nt species, little or no bias for a 5′ G, and production from both sense and antisense strands of the dsRNA administered to the animals to elicit RNAi ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}) ([@R76]). These presumptive primary siRNAs were enriched \>2-fold by oxidation, indicating that at least a subset is modified at their 3′ ends ([Figure 4D](#F4){ref-type="fig"}). Libraries in which the small RNAs were not subjected to oxidation but were treated with RNA 5′ polyphosphatase displayed strong enrichment of small RNAs with features characteristic of 22G-RNAs: predominant length of 22 nts, strong bias for a 5′G, and production antisense to *pos-1* mRNA ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}). Oxidation of small RNAs treated with RNA 5′ polyphosphatase caused a depletion in these presumptive secondary siRNAs derived from *pos-1* ([Figure 4D](#F4){ref-type="fig"}). Furthermore, the length, 5′ nt distribution, and strand polarity of the small RNAs in this library resembled that of primary siRNAs, indicating that the more abundant 22G-RNAs were depleted and, hence, largely unmethylated ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}). In parallel, we assessed whether primary siRNAs are specifically modified in the germline or if somatic siRNAs are also modified. In *glp-4(bn2)* animals, which fail to undergo germline proliferation when grown at 25°C ([@R10]), we did not capture small RNAs aligning to *pos-1* that resembled 22G-RNAs (i.e., 22-nt-long reads containing a 5′G) regardless of whether the small RNAs were treated with RNA 5′ polyphosphatase ([Figure 4E](#F4){ref-type="fig"}). This is likely because *pos-1* is expressed in the germline and, as a consequence, germline-less *glp-4* mutants lack an mRNA template for 22G-RNA production. Primary siRNAs, which are derived from the dsRNA administered to the animals and, therefore, not dependent on an endogenous mRNA template, were strongly enriched by oxidation, suggesting that at least a subset of somatic primary siRNAs is also modified ([Figures 4D](#F4){ref-type="fig"}).

We next assessed whether the 3′ modification that we identified on primary siRNAs is dependent on henn-1 by sequencing small RNAs from wild-type and *henn-1(pk2295)* mutant animals undergoing *pos-1* RNAi. As before, the small RNAs were split into oxidized and non-oxidized fractions; however, each fraction was treated with RNA 5′ polyphosphatase and, thus, both primary and secondary siRNAs were captured. Nonetheless, we could distinguish primary siRNAs from secondary siRNAs by their polarity, as any sense-strand siRNAs are presumably produced from the dsRNA administered to the animals and are, thus, primary siRNAs. In wild-type animals, sense strand siRNAs were enriched \~5-fold in the library from oxidized small RNAs relative to the non-oxidized counterpart, consistent with our earlier conclusion that primary siRNAs are modified ([Figure S4](#SD1){ref-type="supplementary-material"}). In *henn-1(pk2295)* mutants, however, there was no discernable difference between primary siRNA levels in the oxidized and non-oxidized libraries, indicating that the 3′ modification on these small RNAs is lost in *henn-1* mutants ([Figure S4](#SD1){ref-type="supplementary-material"}).

*henn-1* promotes germline RNAi for reasons unknown, although its role in somatic RNAi is confounded by its effect on the ERGO-1-class 26G-RNA pathway, which, when disrupted, enhances RNAi and could, thus, counter modest RNAi defects ([@R11]; [@R31]; [@R72]). Our results indicating that exogenous primary siRNAs are methylated may explain why *henn-1* mutants are partially RNAi-defective in the germline. It is possible, however, that the reduction in *sid-1* and *rde-11* mRNA levels we identified by RNA-seq also contributes to the reduced RNAi sensitivity of *henn-1* mutants, as these genes are also required for optimal RNAi ([@R68]; [@R71]; [@R76]). Our results also demonstrate that each class of small RNAs that acts upstream of the WAGO-class 22G-RNA pathway contains a *henn-1*-dependent 3′ modification. Because HENN-1 is a 3′ methyltransferase, these results suggest that methylation is uniquely associated with primary small RNAs.

Subpopulations of miRNAs Contain 3′-End Modifications {#S8}
-----------------------------------------------------

In addition to binding primary siRNAs during RNAi, RDE-1 interacts with miRNAs ([@R18]). miRNAs are not generally methylated in *C. elegans* ([@R11]; [@R31]; [@R43]), but given our data suggesting that primary siRNAs, which bind RDE-1, are methylated, we tested whether a subset of miRNAs, particularly those bound by RDE-1, might also be methylated. To individually assess miRNA 3′-end modifications, we sequenced small RNAs from wild-type animals after treating the RNA with the oxidizing agent sodium periodate or a control. Consistent with previous studies, piRNAs and ERGO-1-class 26G-RNAs were enriched in libraries prepared from oxidized small RNAs, indicating that they are modified at their 3′ ends ([Figure 5A](#F5){ref-type="fig"}) ([@R11]; [@R31]; [@R43]; [@R50]; [@R63]). Other classes of small RNAs were largely depleted in the oxidized libraries, although a subset of WAGO-class 22G-RNAs was also modestly enriched, which we did not explore further ([Figure 5A](#F5){ref-type="fig"}). Six small RNAs annotated as miRNAs were enriched in libraries from oxidized small RNAs ([Figure 5A](#F5){ref-type="fig"}). Upon closer inspection, two of these small RNAs, miR-78 and miR-4936, bear hallmarks of piRNAs---21 nt long, contain a 5′ U, and are depleted in *prg-1* mutants ([@R49])---suggesting that they are misannotated. Hence, we identified four high-confidence miRNAs, namely, miR-232--5p, miR-240--5p, miR-789, and miR-4814--3p, that were enriched by oxidation and are, therefore, modified at their 3′ ends. Each of these miRNAs was previously shown to interact with RDE-1 ([@R18]). Three of the four miRNAs enriched by oxidation in wild-type animals were truncated in *henn-1* mutants, indicating that *henn-1* protects them from 3′ trimming and is, thus, likely responsible for modifying their 3′ ends ([Figure 5B](#F5){ref-type="fig"}). The levels of the fourth miRNA miR-4814--3p did not pass our read threshold (10 reads per million total) in our wild-type and *henn-1(pk2295)* set of libraries and was not analyzed. These data suggest that a subset of miRNAs is modified at their 3′ ends, and because this modification requires *henn-1*, we conclude that they are likely methylated.

miRNA and Primary siRNA 3′ Modifications Are Dependent on *rde-1* {#S9}
-----------------------------------------------------------------

To determine if RDE-1 could have a role in promoting small RNA methylation or, alternatively, if small RNA methylation might promote RDE-1 association, we first coIP'd RDE-1 from a strain in which a GFP::FLAG cassette was integrated into the endogenous *rde-1* locus using CRISPR-Cas9. Consistent with a previous study in which RDE-1 was coIP'd from an overexpression line, GFP::FLAG::RDE-1 predominantly associated with miRNAs ([Figure 5C](#F5){ref-type="fig"}) ([@R18]). miRNA association with RDE-1 was not dependent on methylation, as GFP::FLAG::RDE-1 largely bound the same miRNAs in both wild-type and *henn-1(pk2295)* mutants ([Figure 5D](#F5){ref-type="fig"}).

We next tested whether miRNA 3′ modifications are dependent on *rde-1*. In parallel to the wild-type animals described above ([Figure 5A](#F5){ref-type="fig"}), we sequenced oxidized and non-oxidized small RNAs from *rde-1(ne219)* mutants. Unlike in wild-type animals, we did not identify any authentic miRNAs that were enriched by oxidation in *rde-1(ne219)* mutants; however, piRNAs, which also contain a *henn-1*-dependent 3′ modification were enriched, indicating that the loss of miRNA modifications is not due to *henn-1* dysfunction in *rde-1* mutants ([Figure 5E](#F5){ref-type="fig"}). Of the four miRNAs enriched by oxidation in our wild-type small RNA sequencing libraries, miR-240--5p was the most strongly enriched in our GFP::FLAG::RDE-1 coIP from *henn-1*+/+ animals (\~1,226-fold) ([Figure 5D](#F5){ref-type="fig"}). miR-240--5p levels were reduced by \~70% in *rde-1* mutants (p = 0.0005), which suggests that RDE-1 is its primary binding partner and that it is destabilized in its absence ([Figure 5F](#F5){ref-type="fig"}). In wild-type libraries prepared from oxidized small RNAs, miR-240--5p was enriched \~12-fold relative to non-oxidized small RNA libraries (p = 0.006) ([Figure 5G](#F5){ref-type="fig"}). In contrast, miR-240--5p was not enriched by oxidation in *rde-1* mutant libraries (p = 1.0) ([Figure 5G](#F5){ref-type="fig"}). miR-240--3p, which is produced from the same precursor as miR-240--5p but from the opposite arm of the miRNA duplex, was only modestly enriched in our GFP::FLAG::RDE-1 coIP from henn-1+/+ animals (\~4-fold) ([Figure 5D](#F5){ref-type="fig"}). We were not able to detect a difference in miR-240--3p levels in *rde-1* mutants ([Figure 5F](#F5){ref-type="fig"}). miR-240--3p was not enriched in oxidized small RNA libraries from either wild-type or *rde-1* mutants, indicating that despite being processed from the same duplex as miR-240--5p, it is not modified at its 3′ end ([Figure 5G](#F5){ref-type="fig"}). Thus, miR-240--5p, a presumably strong RDE-1 interactor, is enriched by oxidation and, therefore, contains a 3′ modification, whereas miR-240--3p, a relatively weak RDE-1 interactor, is not modified. miR-240--3p also associates with ALG-1 and ALG-2 and miR-240--5p associates with ALG-5, suggesting that the fractions of miR-240 that we detected in *rde-1* mutants are likely associated with other Argonautes in an unmethylated form ([@R14]).

Endogenous canonical siRNAs resembling those produced from exogenous dsRNA are also predicted to bind RDE-1. Indeed, we identified endogenous siRNAs produced from the F43E2.6 gene locus that were strongly enriched in our GFP::FLAG::RDE-1 coIPs ([Figure 5H](#F5){ref-type="fig"}). F43E2.6 siRNAs were produced from a duplex that is 23 nt long and has 2-nt 3′ overhangs, indicating that it is likely processed by Dicer and is, therefore, a canonical siRNA locus ([Figure 5H](#F5){ref-type="fig"}) ([@R3]; [@R66]). Furthermore, the levels of F43E2.6 siRNAs were elevated in *mut-16* mutants, indicating that they are not produced through the Mutator pathway, unlike WAGO-class 22G-RNAs ([Figure S5A](#SD1){ref-type="supplementary-material"}) ([@R48]; [@R75]). F43E2.6 siRNAs were modestly elevated in *rde-1* mutants (p ≤ 0.004), suggesting that association with RDE-1 destabilizes them relative to other Argonautes they might interact with or that their production is elevated in the absence of *rde-1* ([Figure 5I](#F5){ref-type="fig"}). Both sense and antisense F43E2.6 siRNAs were enriched in GFP::FLAG::ALG-1 coIPs, indicating that they are partitioned between at least two Argonautes ([Figure S5B](#SD1){ref-type="supplementary-material"}) ([@R14]). In wild-type samples, the F43E2.6 sense strand siRNA was enriched by \~30-fold and the antisense siRNA by \~55-fold in oxidized small RNA libraries relative to non-oxidized small libraries, indicating that both strands of the duplex contain a 3′ modification (p ≤ 0.0005) ([Figure 5J](#F5){ref-type="fig"}). Conversely, neither siRNA was enriched in oxidized small RNA libraries from *rde-1* mutants, suggesting that accumulation of these siRNAs in their 3′ modified form is dependent on their association with RDE-1 ([Figure 5J](#F5){ref-type="fig"}). These results point to a link between RDE-1 association and miRNA and primary siRNA 3′ modification, a modification dependent on *henn-1* and, therefore, likely methylation, and thus, we speculate that RDE-1 may direct small RNA methylation.

DISCUSSION {#S10}
==========

The germline mortality of *henn-1* mutants likely relates to its role in the piRNA pathway, as disrupting the other small RNA pathways that *henn-1* is implicated in, those involving the Argonautes ERGO-1 and RDE-1, does not result in progressive sterility ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}) ([@R52]). The progressive sterility of *henn-1* mutants follows a similar, albeit temperature sensitive, progression to that of *prg-1/piwi* mutants ([@R59]). Immediate sterility ensues after reestablishing the WAGO pathway, and therefore endogenous RNAi, in the absence of maternal *henn-1* or *prg-1* ([@R19]; [@R49]). Animals heterozygous for *henn-1* in which the wild-type copy of the gene was contributed by the father, which presumably becomes active at the maternal-to-zygotic transition that occurs at the \~28-cell stage, displayed equal rates of sterility to animals homozygous mutant for *henn-1* after reestablishing endogenous RNAi. Thus, a model emerges in which maternally inherited methylated piRNAs and/or *henn-1* establish proper RNA silencing during embryogenesis, which presumably persists throughout germline development to ultimately impact fertility. This would likely occur through the initiation of secondary WAGO-class 22G-RNA production, which is thought to provide a memory of piRNA activity ([@R8]; [@R15]; [@R40]; [@R57]). In support of this, we observed similar effects on 22G-RNA levels across development in *henn-1* mutants, despite *henn-1* only being required for piRNA stability in embryos and early larval stages ([@R11]).

Although *henn-1*, and by extension methylation, has an important role in germline proliferation, it appears to have little impact on piRNA stability in the adult germline. Why methylation is important for piRNA stability in embryos but not in adult germ cells is unclear. It is possible that the genes involved in piRNA decay in embryos are absent in adults; however, we saw a similar degree of piRNA trimming in wild-type embryos and adults, suggesting there may be two distinct mechanisms for piRNA decay, only one of which is affected by methylation. Alternatively, methylation may be specifically required for stabilizing piRNAs during maternal deposition in the embryo. P granules, the germ granules that house PRG-1/Piwi, break away from nuclear envelope after fertilization, possibly releasing piRNAs into the cytoplasm, which may expose them to decay machinery that they are normally protected from in P granules ([@R55]). It is also possible that piRNAs engage a distinct set of targets in embryos to which they have extensive complementarity at their 3′ ends and as a consequence are more susceptible to target-directed decay. This would hint at a role for piRNAs in early development that is perhaps distinct from their role later in development. piRNA-mRNA interactions that require only partial complementarity, which is common in *C. elegans* ([@R56]; [@R77]), may not be affected by methylation. Modulation of methylation may even promote one function of piRNAs over another, which could explain why genes misregulated in *henn-1* mutants, despite nearly all being potential piRNA targets, were not uniformly up- or downregulated.

Our results demonstrate that small RNAs that act upstream of the Mutator complex, the WAGO-class 22G-RNA amplification component of the RNAi pathway, contain a 3′ modification that is dependent on *henn-1* and, thus, presumably methylation, whereas those that do not act as primary small RNAs are not modified ([@R11]; [@R31]; [@R43]). The Mutator complex contains a nucleotidyltransferase (MUT-2) and a 3′--5′ exonuclease (MUT-7), both of which could promote decay of primary small RNAs that feed into the pathway ([@R48]). It is possible that methylation protects primary small RNAs from degradation by the RNAi machinery or by factors that bridge the primary and secondary small RNA pathways. In support of this model, in *Arabidopsis*, methylation protects small RNAs from uridylation by HESO1, which is recruited to mRNA targets by the Argonaute AGO1 to facilitate decay of the 5′ fragment generated by AGO1 cleavage ([@R65]).

We showed that *rde-1* is required for the accumulation of miRNAs and canonical siRNAs containing modifications at their 3′ ends. Although we identified only a small subset of miRNAs that were resistant to oxidation, an indicator of the presence of a 3′ modification, most miRNAs were enriched in our RDE-1 coIPs. Therefore, if RDE-1 directs small RNA methylation, subpopulations of most individual miRNAs are likely methylated. Methylated miRNAs bound to RDE-1 may have a distinct function from non-methylated miRNAs bound to the other miRNA-associated Argonautes, ALG-1, ALG-2, and ALG-5. miR-243, for example, promotes mRNA entry into the endogenous RNAi pathway through its association with RDE-1 ([@R18]). miR-243, however, was not enriched by oxidation possibly because it also binds strongly to ALG-1 ([@R14]). In *Drosophila*, miRNAs predominantly associate with Ago1 and are not methylated; however, some also associate with the predominantly siRNA-associated Argonaute Ago2 and are methylated, consistent with *Drosophila* Ago2 directing small RNA methylation ([@R4]; [@R27]). It seems an analogous system may exist in *C. elegans* between the miRNA-associated Argonaute ALG-1, ALG-2, and ALG-5 and the exogenous siRNA-Argonaute RDE-1. It was recently shown that miRNAs are methylated in sea anemones, which commonly interact with near-perfect complementarity to their targets ([@R42]). Together with these studies, our results raise the possibility that some degree of miRNA methylation is common in animals.

STAR★METHODS {#S11}
============

Detailed methods are provided in the online version of this paper and include the following:

LEAD CONTACT AND MATERIALS AVAILABILITY {#S12}
=======================================

Requests for information and resources should be directed to and will be fulfilled by the lead contact, Taiowa Montgomery (tai. <montgomery@colostate.edu>). All *C. elegans* strains generated in this study are available on request from the Lead Contact without restriction.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S13}
======================================

The [Key Resources Table](#S12){ref-type="sec"} contains all of the *C. elegans* strains used in this study. Hermaphroditic animals were grown on nematode growth medium and fed *E. coli* OP50, except where noted otherwise. Animals used in the experiments in [Figures 1A](#F1){ref-type="fig"}, [1B](#F1){ref-type="fig"}, [1F](#F1){ref-type="fig"}, [1G](#F1){ref-type="fig"}, [4](#F4){ref-type="fig"}, [S1A](#SD1){ref-type="supplementary-material"}--[S1C](#SD1){ref-type="supplementary-material"}, [S1E](#SD1){ref-type="supplementary-material"}, and [S4](#SD1){ref-type="supplementary-material"} were grown at 25°C. All other animals were grown at 20°C. The developmental stage at which the animals were analyzed is specified in the methods and figures.

METHOD DETAILS {#S14}
==============

Strain Generation {#S15}
-----------------

USC1080\[rde-1(cmp133\[(gfp + loxP + 3xFLAG)::rde-1\]) V\] and USC988\[mut-16(cmp41\[mut-16::mCherry + loxP\]) wago-1(cmp92 \[(GFP + loxP + 3xFLAG)::wago-1\]) I\] were generated by introducing a GFP::3xFLAG cassette at the 5′ end of the endogenous *rde-1* or *wago-1* coding sequence using CRISPR-Cas9 genome editing ([@R7]; [@R20], [@R21]). The repair templates were amplified using primers listed in [Table S5](#SD6){ref-type="supplementary-material"} and introduced into the vector pDD282 (Addgene \#66823) by isothermal assembly ([@R24]). To protect the repair template from cleavage, a mutation of the PAM sequence was incorporated into one of the primers. The guide RNA plasmid was generated by ligating oligos containing the guide RNA sequence into BsaI-digested pRB1017 (Addgene \#59936) ([@R20]). TAM18 \[*henn-1(ram13\[henn-1ko; mCherry::Flag-no-stop-codon\]) III*\] was also generated using CRISPR-Cas9 ([@R20]). The repair template was amplified with the primers listed in [Table S5](#SD6){ref-type="supplementary-material"} and introduced into SpeI and ClaI digested pJJR83 (Addgene \#75028). The guide RNA construct was generated with the NEBuilder kit (New England BioLabs, E2621) using the plasmid pDD162 (Addgene \#47549) and the primers listed in the [Table S5](#SD6){ref-type="supplementary-material"}. The entire *henn-1* coding sequence was replaced with an mCherry::3xFLAG cassette lacking a stop codon and thus does not express mCherry. TAM226\[*mut-16(pk710) I; henn-1(pk2295) III*\], TAM236\[*mut-16(pk710) I; henn-1(ram13) III*\], TAM27\[*henn-1(pk2295) III; mut-14(mg464) smut-1(tm1301) V*\], and TAM35\[*henn-1(ram13) III; mut-14(mg464) smut-1(tm1301) V*\] were generated using standard genetic methods.

Multigenerational Brood Size Assays {#S16}
-----------------------------------

Worms were grown on a continuous supply of *E. coli* (OP50) and chunked to fresh plates at each new generation (every 2--3 days). Because animals lay eggs over multiple days, the number of generations is approximate. Brood size assays were performed by separating 15 L4 larvae per strain onto individual plates, removing their offspring twice per day, and recording the number removed until the animals were no longer laying eggs. P values were calculated using Wilcoxon rank-sum tests.

Transgenerational Sterility Assays {#S17}
----------------------------------

Transgenerational sterility assays were modeled after the approach used by [@R59] and [@R1]. Briefly, 10 independent lines per wild-type, *henn-1(pk2295)*, *prg-1(n4357)*, and *ergo-1(tm1860)* strain were grown at 20°C or 25°C. 10 worms per line were transferred to new plates every generation (2--3 days at 25°C or 3--4 days at 20°C) for 30 generations, and fertility was recorded at each transfer. Animals producing any number of offspring were considered fertile, and all offspring were transferred from plates on which there were fewer than 10 viable progeny.

Reestablishing Endogenous RNAi {#S18}
------------------------------

The RNAi pathway was restored in RNAi-defective mutants using the genetics approach illustrated in [Figure 1C](#F1){ref-type="fig"} as described ([@R49]). Individual F1 animals from each cross were genotyped to confirm heterozygosity of *smut-1(tm1301)*, indicating that the progeny were from a cross. Animals that were wild-type or homozygous mutant for *smut-1* were excluded from the analysis. P values were calculated using two-sample t tests.

Imaging {#S19}
-------

Animals were imaged on a Zeiss Axio Imager Z2 upright microscope after immobilization in 10--25 uM sodium azide on 1.5% Agarose pads on glass slides.

Gonad Dissections {#S20}
-----------------

Animals were grown to gravid adult stage at 20°C for 68--70 hours after L1 synchronization and dissected by cutting posterior to the pharynx or anterior to the tail in egg buffer containing 10 mM levamisole. Extruded distal gonads were collected by mouth pipetting, transferred to 500 ul Trizol, and frozen at −80°C ([@R16]). Because the gonads break at the arms, the samples did not include the proximal gonad arms, which contain mature oocytes and sperm.

RNA Isolation {#S21}
-------------

Dissected gonads and whole animals were flash frozen in liquid nitrogen prior to RNA isolation. RNA was isolated using Trizol (Life Technologies) followed by two chloroform extractions. RNA was precipitated in isopropanol for 20 minutes at room temperature for whole animal samples and overnight at −80°C in the presence of 20 ug glycogen for germline, input, and co-IP samples.

Quantitative Real-Time PCR {#S22}
--------------------------

Quantitative real-time-PCR of small RNAs was done as described using TaqMan reagents and custom probes following the manufacturers recommendations ([@R11]; [@R43]). Ct values were captured using a Bio-Rad CF96 Real-Time PCR Detection System. Ct values were averaged across three technical replicates. Mean relative 21U-RNA levels across 3 biological replicates were calculated using the 2^−ddCt^ method ([@R38]). miR-35 levels were used for normalization. Two-sample t tests were used to compare differences between samples. Bonferroni adjustments were applied to correct for multiple comparisons.

Small RNA Northern Blot {#S23}
-----------------------

10 ug total RNA from each sample was resolved on a 17% denaturing polyacrylamide gel, transferred to a Hybond-N+ membrane (GE Healthcare), and UV crosslinked. T4 polynucleotide kinase (NEB) was used to radiolabel an LNA oligonucleotide antisense to 21UR-1 with ^32^P-ATP. The membrane was incubated with the probe overnight at 38°C in PerfectHyb Plus Hybridization Buffer (Sigma) and washed 5 times in SSC/SDS buffer at 50°C for 20 minutes each wash.

Small RNA-Seq Libraries {#S24}
-----------------------

Small RNAs were size selected (\~16--30 nt) on 17% polyacrylamide/urea gels. Small RNA treatment varied by library as indicated in [Table S6](#SD7){ref-type="supplementary-material"}. Oxidation to enrich for 3′-2′-O-methylated small RNAs was done using 200 mM sodium periodate in borate buffer (pH 8.6) as described, but without beta-elimination ([@R43]; [@R73]). Polyphosphatase treatment to reduce 5′ di- and triphosphates to monophosphates was done using RNA 5′ polyphosphatase (Illumina). High-throughput sequencing libraries were prepared as described ([@R14]) or using the NEBNext Multiplex Small RNA Library Prep Kit (Illumina) ([Table S6](#SD7){ref-type="supplementary-material"}). The 3′ ligation was done at 16°C for 18 hours to improve capture of methylated small RNAs. PCR amplicons were size selected on 10% polyacrylamide non-denaturing gels.

Small RNA-Seq Data Analysis {#S25}
---------------------------

16--30 nt small RNA sequences were parsed from the library adapters, filtered to exclude reads with \>1 base having a Phred quality score \< 30 and mapped to the *C. elegans* genome (Wormbase release WS230) using CASHX v. 2.3 ([@R23]). miRNAs, piRNAs, WAGO-class 22G-RNA loci, CSR-1-class 22G-RNA loci, ALG-3/4-class 26G-RNA loci, and ERGO-1-class 26G-RNA loci were classified as described ([@R49]). Differential expression analysis, including fold change and p value calculations, was done using DESeq2 v. 1.18.1 with the Benjamin Hochberg multiple test correction applied (FDR = 0.05) ([@R39]). All other p values reported for small RNA sequencing data were calculated using two-sample t tests. Custom Perl and Python scripts, R, and Excel were used for all other data analyses. Plots were drawn in R, Excel, BioVenn, and IGV ([@R28]; [@R62]). Sequencing was done on an Illumina NextSeq 500 (High Output Kit, 75 cycles) at the Colorado State University Next-Gen Sequencing Core.

RNA-Seq Libraries {#S26}
-----------------

Ribosomal RNA was depleted from total RNA using Ribo-Zero rRNA Removal Kit (Human/Mouse/Rat) (Illumina). rRNA depleted RNA was purified using the RNA Clean & Concentrator kit (Zymo Research). DNase treatment was done on the columns used for RNA purification. High-throughput sequencing libraries were prepared from purified rRNA-depleted RNA using NEBNext Ultra II Directional RNA Library Prep Kit (NEB). Most sequencing was done on an Illumina NextSeq 500 (High Output Kit, 75 cycles) at the Colorado State University Next-Gen Sequencing Core. ([Table S6](#SD7){ref-type="supplementary-material"}).

RNA-Seq Data Analysis {#S27}
---------------------

Adapters and low-quality bases were removed using Trimmomatic v. 0.35 ([@R13]). Reads were mapped to the *C. elegans* genome (Wormbase release WS230) using Star v. 2.5.0a ([@R22]). Reads from specific genes were counted using RSEM v. 1.3.0 ([@R36]). Differential expression analysis, including fold change and p value calculation, was done using DESeq2 v. 1.18.1 with the Benjamin Hochberg multiple test correction applied (FDR = 0.05) ([@R39]). Plots were drawn with R and IGV ([@R62]).

Transposon Analysis {#S28}
-------------------

To identify reads mapping to each annotated transposon family, mRNA and small RNA sequencing reads were aligned to each of 152 transposon family consensus sequences using Bowtie ([@R34]; [@R29]). Reads mapping to more than one transposon family were discarded. Differential expression analysis, including fold change and p value calculation, was done using DESeq2 v. 1.18.1 ([@R39]).

RNAi Assays {#S29}
-----------

Synchronized L1 larvae were transferred to plates with *E. coli* HT115 containing an empty vector (L4440) or expressing dsRNA complementary to *pos-1* ([@R30]) and grown at 25°C. Gravid adults were collected for RNA isolation at 48 hours.

Co-Immunoprecipitations {#S30}
-----------------------

FLAG::HRDE-1, GFP::FLAG::WAGO-1, and GFP::FLAG::RDE-1 were coimmunoprecipitated from gravid adults 68 hours after L1 synchronization. Animals were flash frozen in liquid nitrogen and lysed in 50 mM Tris-Cl, pH 7.4, 100 mM KCl, 2.5 mM MgCl~2~, 0.1% Igepal CA-630, 0.5 mM PMSF, and 1X Pierce Protease Inhibitor Tablets. Cell lysates were cleared by centrifugation for 10 min at 12,000 RCF and incubated with anti-GFP mAb-agarose for 1 hour or with anti-FLAG followed by Protein G magnetic beads for a combination of 1 hour. After co-immunoprecipitation, beads were washed in lysis buffer and split into RNA and protein fractions. All steps were done at 4°C. Antibody specificity for FLAG (FLAG::HRDE-1, GFP::FLAG::WAGO-1 co-IPs) or GFP (GFP::FLAG::RDE-1) was confirmed by doing negative control co-IPs from wild-type animals.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S31}
=======================================

The statistical tests used are described within the methods section describing each experiment. Bonferroni multiple test corrections were applied to p values when comparing \>2 conditions.

DATA AND CODE AVAILABILITY {#S32}
==========================

All the high-throughput sequencing data described here has been deposited to the Gene Expression Omnibus (GEO) and is freely available under accession number GEO: GSE137734. Software used in the study is described in the corresponding methods section and the [Key Resources Table](#S12){ref-type="sec"}. Custom R, Perl, and Python scripts are freely available on request.
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======================

Thanks to Mark Stenglein, Justin Lee, and Marylee Layton for assistance with sequencing; Dustin Updike for training in gonad dissections and for providing the *glh-1::GFP* strain; and Rene Ketting for providing *henn-1(pk2452)*. Additional strains were provided by the CGC, which is funded by the NIH (P40 OD010440). This work was supported by the Boettcher Foundation (003614--00002 to T.A.M.), the NIH (R35GM119775 to T.A.M., T32GM132057 to K.J.R., R35GM119656 to C.M.P., and T32GM118289 to D.H.N.), and Pew Charitable Trusts (C.M.P.).

DECLARATION OF INTERESTS

The authors declare no competing interests.

SUPPLEMENTAL INFORMATION

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2019.10.114>.

![Sterility Ensues in the Absence of *henn-1*\
(A) Brood sizes at \~5 generations (wild-type, n = 12; *henn-1*, n = 17; *prg-1*, n = 15), \~15 generations (wild-type, n = 10; *henn-1*, n = 15; *prg-1*, n = 13), and \~28 generations (wild-type, n = 13; *henn-1*, n = 15; *prg-1*, n = 15). The numbers of sterile animals at \~28 generations are shown. p \< 0.002 for all comparisons to wild-type (see [Figure S1A](#SD1){ref-type="supplementary-material"}). Error bars report standard deviation.\
(B) Brood sizes at \~5 generations (wild-type, n = 14; *henn-1*, n = 12) and \~20 generations (wild-type, n = 12; *henn-1*, n = 11). The numbers of sterile animals at \~20 generations are shown. Individual data points and p values are in [Figure S1B](#SD1){ref-type="supplementary-material"}. Error bars report standard deviation.\
(C) The genetics-based approach used to reestablish WAGO-class 22G-RNA production and, thus, endogenous RNAi in *henn-1*^+/+^ or *henn-1*^−/−^ animals. RNAi competency is indicated by RNAi+ or RNAi--.\
(D) Mean percentage of F1 progeny from the crosses illustrated in (C) that were sterile (n = 2 biological replicates each assaying the progeny from 7--27 crosses). Error bars report standard deviation.\
(E) Same as in (D) but with the *henn-1(ram13)* allele. The *henn-1* genotype is indicated and because both parents are homozygous mutant or wild-type for *henn-1*, the genotype applies to both the P0 parents and the F1 progeny (n = 4 independent experiments each assaying the progeny from 11--34 crosses). Error bars report standard deviation.\
(F) Differential interference contrast (DIC) and GFP fluorescence images of the diminutive germlines of sterile *glh-1::GFP; henn-1(pk2295)* animals. An image of the germline of a *glh-1::GFP* animal wild-type for *henn-1* is shown as a control. Strains were grown at 25°C for 10 generations. The colored bars under the images relate to the key in (G).\
(G) Numbers of *henn-1*^+/+^ and *henn-1*^−/−^ animals displaying germline defects exemplified in (F), as indicated in the key.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1545819-f0002){#F1}

![Requirement for *henn-1* in piRNA Stability and WAGO-Class 22G-RNA Production\
(A) The proportions of total high-throughput sequencing reads for piRNAs and WAGO-class 22G-RNAs in embryos and dissected gonads are plotted by size. Mean reads per library are shown as thousand reads per million total mapped reads (kRPM) (n = 3 biological replicates). Error bars report standard deviation.\
(B) The proportions of total piRNA reads that display 1- to 5-nt truncations (mean trimmed reads/total reads) in embryos and dissected gonads (n = 3 biological replicates). Error bars report standard deviation.\
(C and D) qRT-PCR assay of three piRNAs in embryos (C) and dissected gonads (D) (n = 3 biological replicates for each assay). The mean cycle threshold (ct) value is shown for each assay. piRNA ct values were normalized to miR-35 ct values. Error bars report standard deviation.\
(E) Northern blot of the piRNA 21UR-1 in embryos and adults. Ethidium bromide (EtBr)-stained tRNAs are shown as a loading control. Two of three biological replicates are shown.\
(F) Normalized WAGO-class 22G-RNA reads (reads per million total mapped reads) in wild type (x axis) and *henn-1(pk2295)* (y axis). Data from embryos, L4 larvae, and gravid adults are shown (no biological replicates).\
(G) Venn diagram displaying the overlap in genes depleted of WAGO-class 22G-RNAs by \>50% in henn-1(pk2295) embryos, L4 larvae, and adults.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1545819-f0003){#F2}

![Differential Expression of mRNAs and Small RNAs in *henn-1* Gonads\
(A) Scatterplot displaying each gene as the average number of normalized reads in wild type (x axis) and *henn-1(pk2295)* (y axis) (n = 3 biological replicates). Grey lines are at −2-, 1-, and 2-fold change relative to wild type. Dashed lines are at 10 reads on each axis.\
(B) Scatterplot displaying each WAGO and CSR-1 target gene as the average number of normalized small RNA reads in wild type (x axis) and *henn-1(pk2295)* (y axis) (n = 3 biological replicates).\
(C) Pie charts displaying the proportions of genes upregulated or downregulated in *henn-1(pk2295)* (p \< 0.05) belonging to each of the indicated classes.\
(D) Scatterplot displaying each transposon family as the average number of normalized mRNA reads in wild type (x axis) and *henn-1(pk2295)* (y axis) (n = 3 biological replicates).\
(E) Scatterplot displaying each transposon family as the average number of normalized small RNA reads in wild type (x axis) and *henn-1(pk2295)* (y axis) (n = 3 biological replicates).\
(F) mRNA and small RNA read distribution across the MIRAGE transposon consensus sequence. One of three biological replicates is shown.\
(G) Scatterplot displaying fold change in mRNA levels in *henn-1(pk2295)* relative to wild type for each gene depleted of 22G-RNAs \>1.3-fold in *henn-1(pk2295)*.\
(H) Venn diagrams displaying the overlap between genes depleted of 22G-RNAs in *henn-1(pk2295)* and genes that yield 22G-RNAs enriched \>1.3-fold in WAGO-1 or HRDE-1 coIPs. The three-way Venn diagram is a combination of the two-way Venn diagrams.\
See also [Figure S3](#SD1){ref-type="supplementary-material"} and [Tables S1](#SD2){ref-type="supplementary-material"}, [S2](#SD3){ref-type="supplementary-material"}, [S3](#SD4){ref-type="supplementary-material"}, and [S4](#SD5){ref-type="supplementary-material"}.](nihms-1545819-f0004){#F3}

![Primary siRNAs Are Modified at Their 3′ Ends\
(A) Model depicting the interplay between RNA surveillance and WAGO-class 22G-RNA production by the RNAi pathway.\
(B) Size distribution and 5′ nucleotide composition of *pos-1* siRNAs following *pos-1* RNAi, as determined by high-throughput sequencing. Small RNAs were treated with sodium periodate (oxidation) to enrich for methylated small RNAs or subjected to a control treatment prior to library preparation. The "1° siRNAs" plot corresponds to libraries in which the small RNAs were not treated with RNA 5′ polyphosphatase and, thus, do not include di- and tri-phosphorylated small RNAs (e.g., 22G-RNAs). The "All siRNAs" plot corresponds to libraries in which the small RNAs were treated with RNA 5′ polyphosphatase and, thus, include both 1° and 2° siRNAs.\
(C) Small RNA read distribution across *pos-1* from wild-type high-throughput sequencing libraries in which the small RNAs were treated with sodium periodate (oxidation +) and RNA 5′ polyphosphatase (polyphosphatase +) as indicated.\
(D) Bar plots displaying normalized reads (reads per million total mapped reads) mapping to *pos-1* following sodium periodate (oxidation +) or control treatment (oxidation --). The plots on the left are from wild-type animals, and the plot on the right is from *glp-4(bn2)* mutants, which lack proliferated germlines and for which only primary siRNAs are shown.\
(E) Small RNA read distribution across *pos-1* from *glp-4(bn2)* high-throughput sequencing libraries in which the small RNAs were treated with sodium periodate (oxidation +) and RNA polyphosphatase (polyphosphatase +) as indicated.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1545819-f0005){#F4}

![Accumulation of Modified miRNAs and Primary siRNAs Is Dependent on *rde-1*\
(A) Scatterplot displaying each small RNA feature (miRNA, piRNA, WAGO-class 22G-RNA locus, CSR-1-class 22G-RNA locus, ALG-3/4-class 26G-RNA locus, and ERGO-1-class 26G-RNA locus) as the average number of normalized reads in control (x axis, ox--) and oxidized small RNA libraries (y axis, ox+) (n = 3 biological replicates). Data are from wild-type L4-stage animals.\
(B) The proportions of total reads for each miRNA in L4 larvae are plotted by size. The "all miRNAs" plot corresponds to the combined proportions of reads for all annotated miRNAs. The data do not contain biological replicates.\
(C) Enrichment or depletion of the indicated classes of small RNAs in GFP::FLAG::RDE-1 coIPs relative to cell lysates. Data are shown for 1 of 2 biological replicates.\
(D) Scatterplot displaying each miRNA as its enrichment in GFP::FLAG::RDE-1 coIPs relative to cell lysates from adult animals wild type (*henn-1*+/+) (x axis) or mutant for *henn-1* (*henn-1(pk2295)*) (y axis). Dashed lines are at 1-fold enrichment on each axis.\
(E) Scatterplot displaying each small RNA feature, as in (A), as the average number of normalized reads in control (x axis, ox--) and oxidized small libraries (y axis, ox+) (n = 3 biological replicates). Data are from *rde-1(ne219)* L4-stage animals grown in parallel to the wild-type animals used in (A).\
(F) miR-240--5p and miR-240--3p reads in *rde-1(ne219)* relative to wild type (n = 3 biological replicates). Error bars report standard deviation.\
(G) miR-240--5p and miR-240--3p reads in wild type and *rde-1(ne219)* from small RNA libraries treated with sodium periodate (oxidation +) relative to libraries receiving a control treatment (oxidation --) (n = 3 biological replicates). Error bars report standard deviation.\
(H) Read distribution across the F43E2.6 siRNA-generating locus from *GFP::FLAG::rde-1* cell lysate (input, top plot) and GFP::FLAG::RDE-1 coIP small RNA libraries (bottom plot). The most abundant siRNA duplex produced from the locus is shown. Enrichment in the GFP::FLAG::RDE-1 coIP relative to the input is shown for each siRNA.\
(I) F43E2.6 sense and antisense siRNA reads in *rde-1(ne219)* relative to wild type (n = 3 biological replicates). Error bars report standard deviation.\
(J) F43E2.6 sense and antisense siRNA reads in wild type and *rde-1(ne219)* from small RNA libraries treated with sodium periodate (oxidation +) relative to libraries receiving a control treatment (oxidation --) (n = 3 biological replicates). Error bars report standard deviation.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1545819-f0006){#F5}

  REAGENT or RESOURCE                                                                          SOURCE                                                    IDENTIFIER
  -------------------------------------------------------------------------------------------- --------------------------------------------------------- -------------------------------------------------------------------
  Antibodies                                                                                                                                             
  anti-GFP mAb-agarose                                                                         MBL                                                       Cat\# D153--8; RRID:AB_591815
  anti-FLAG                                                                                    Sigma                                                     Cat\# F1804; RRID:AB_262044
  Bacterial Strains                                                                                                                                      
  *E. coli* OP50                                                                               Gary Ruvkun (Harvard Medical School)                      N/A
  *E. coli* HT115                                                                              Gary Ruvkun (Harvard Medical School) ([@R30])             N/A
  Chemicals, Peptides, and Recombinant Proteins                                                                                                          
  Trizol                                                                                       Life Technologies                                         15596018
  RNA 5′ polyphosphatase                                                                       Illumina                                                  RP8092H
  NEBNext 2X PCR Master Mix                                                                    NEB                                                       M0541L
  TURBO DNase                                                                                  Life Technologies                                         AM2238
  AMPure XP Beads                                                                              Beckman Coulter                                           A63881
  Pierce Protease Inhibitor Tablets                                                            Pierce Biotechnology                                      88266
  Amersham Hybond -N+ Membranes                                                                GE Healthcare                                             RPN303B
  PerfectHyb Plus Hybridization Buffer                                                         Sigma-Aldrich                                             H7033
  T4 Polynucleotide Kinase (3′ phosphatase minus)                                              NEB                                                       M0236S
  SureBeads Protein G Magnetic Beads                                                           Bio-Rad                                                   161--4023
  Critical Commercial Assays                                                                                                                             
  TaqMan                                                                                       Life Technologies                                         4366596, 4444557, 4427975
  NEBNext Ultra II Directional RNA Library Prep Kit for Illumina                               NEB                                                       E7760S
  RNA Clean & Concentrator                                                                     Zymo Research                                             R1015
  Ribo-Zero rRNA Removal Kit (Human/Mouse/Rat)                                                 Illumina                                                  MRZH11124
  NEBNext Small RNA Library Prep Kit for Illumina                                              NEB                                                       E7300S or E7580S
  Deposited Data                                                                                                                                         
  NGS data                                                                                     This Study                                                Gene Expression Omnibus GSE137734
  Experimental Models: Organisms/Strains                                                                                                                 
  *C. elegans* Bristol Strain                                                                  CGC                                                       N2
  *glp-4(bn2) I*                                                                               CGC                                                       SS104
  *henn-1(pk2295) III*                                                                         René Ketting (IMB Mainz)                                  NL4415
  *prg-1(n4357) I*                                                                             CGC                                                       SX922
  *rde-1(ne219) V*                                                                             CGC                                                       WM27
  *mut-14(mg464) smut-1(tm1301) V*                                                             [@R49]                                                    GR1948
  *mut-16(pk710) I*                                                                            *CGC*                                                     NL1810
  *henn-1(pk2452) III*                                                                         René Ketting (IMB Mainz)                                  RFK30
  *glh-1(sam24\[glh-1::gfp::3Xflag\]) I*                                                       Dustin Updike (MDI)                                       DUP64
  *glh-1(sam24\[glh-1::gfp::3Xflag\]) I; henn-1(pk2295) III*                                   This Study                                                TAM56
  *rde-1(cmp133\[(gfp + loxP + 3xFLAG)::rde-1\]) V*                                            This Study                                                USC1080
  *mut-16(cmp41\[mut-16::mCherry + loxP\]) wago-1(cmp92\[(GFP + loxP + 3xFLAG)::wago-1\]) I*   This Study                                                USC988
  *henn-1(ram13\[henn-1ko; mCherry::Flag-no-stop-codon\]) III*                                 This Study                                                TAM18
  *mut-16(pk710) I; henn-1(pk2295) III*                                                        This Study                                                TAM26
  *mut-16(pk710) I; henn-1(ram13) III*                                                         This Study                                                TAM36
  *henn-1(pk2295) III; mut-14(mg464) smut-1(tm1301) V*                                         This Study                                                TAM27
  *henn-1(ram13) III; mut-14(mg464) smut-1(tm1301) V*                                          This Study                                                TAM35
  *flag::hrde-1(\[flag::hrde-1, cb-unc-119(+)\]) II; unc-119(ed3) III*                         Craig Mello (University of Massachusetts) ([@R57])        N/A
  Oligonucleotides                                                                                                                                       
  See [Table S5](#SD6){ref-type="supplementary-material"}                                      See [Table S5](#SD6){ref-type="supplementary-material"}   N/A
  Recombinant DNA                                                                                                                                        
  pDD282 (GFP::3xFLAG repair template plasmid)                                                 Addgene ([@R21])                                          66823
  pRB1017 (Guide RNA plasmid)                                                                  Addgene ([@R7])                                           59936
  pJJR83 (mCherry::3xFLAG repair template plasmid)                                             Addgene (a gift from Mike Boxem)                          75028
  pDD162 (Guide RNA plasmid)                                                                   Addgene ([@R20])                                          47549
  L4440 (RNAi vector)                                                                          Addgene (a gift from Andrew Fire)                         1654
  pos-1 RNAi plasmid                                                                           Gary Ruvkun (Harvard Medical School) ([@R30])             N/A
  Software and Algorithms                                                                                                                                
  CASHX v. 2.3                                                                                 [@R23]                                                    N/A
  DESeq2 v. 1.18.1                                                                             [@R39]                                                    <https://bioconductor.org/packages/release/bioc/html/DESeq2.html>
  Trimmomatic v. 0.35                                                                          [@R13]                                                    <http://www.usadellab.org/cms/?page=trimmomatic>
  Star v. 2.5.0a                                                                               [@R22]                                                    <https://github.com/alexdobin/STAR>
  Bowtie                                                                                       [@R34]                                                    <http://bowtie-bio.sourceforge.net/index.shtml>
  RSEM v. 1.3.0                                                                                [@R36]                                                    <https://deweylab.github.io/RSEM/>
  Zen Image Analysis                                                                           Zeiss                                                     N/A

###### Highlights

-   *henn-1* mutants display transgenerational sterility

-   Maternal *henn-1* is required to establish proper RNA silencing

-   HENN-1 stabilizes piRNAs in embryos but is dispensable in the adult germline

-   RDE-1-associated siRNAs and miRNAs are modified at their 3′ ends by HENN-1
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